Argentina's New Hemp and Medical Cannabis Regulator

Home | Canna Law Blog | Argentina’s New Hemp and Medical Cannabis Regulator Table of Contents Toggle Earlier this month, we discussed the approval of a new regulatory framework for hemp and medical cannabis by Argentina's legislature. At the time, we focused our attention on those who, reflecting antiquated thinking on cannabis, voted against the bill. Today we finally turn to the substance of what is officially known as the Regulatory Framework for the Development of the Medical Cannabis and Industrial Hemp Industry (Marco Regulatorio para el Desarrollo de la Industria del Cannabis Medicinal y el Cáñamo Industrial). Yes, it's a mouthful. The new regulator The recently passed law establishes the Regulatory Agency for the Hemp and Medical Cannabis Industry, or ARICCAME (Agencia Regulatoria de la Industria del Cáñamo y del Cannabis Medicinal), a part of the Ministry of Productive Development (Ministerio de Desarrollo Productivo). The agency "will be the competent organism to regulate, control and issue administrative licenses with respect to the use of cannabis seeds, cannabis and its derivate products." Based in Argentina's capital of Buenos Aires, ARICCAME is empowered to establish branch offices across Argentina. Advising the regulator A Federal Council for the Development of the Hemp and Medical Cannabis Industry (Consejo Federal para el Desarrollo de la Industria del Cáñamo y Cannabis Medicinal) has also been created. This council will serve as an advisory body to ARICCAME. Its composition (one representative of the national government and one for each of Argentina's provinces) appears geared to amplify the voices of Argentina's less populated provinces when it comes to hemp and medical cannabis policy. Among its tasks is recommending to ARICCAME of policies that encourage the "harmonious development of the industry in each region." Licensure and social equity Under the new framework, ARICCAME is responsible for issuing licenses to import, export, cultivate, industrially produce, manufacture, market and acquire cannabis seeds, cannabis and its derivate products. The agency is explicitly required to establish objective criteria for applicants. In exercising its licensure function, Argentina's new regulator is to "have special consideration toward applications oriented to contributing to the development of regional economies and promote the activities of cooperatives and agricultural SMEs." In addition, ARICCAME must consider "the inclusion of gender perspective and diversity" when issuing hemp and medical cannabis licenses. Penalties The new law establishes penalties for regulatory violations. These include the cancellation of licenses when the holder does not engage in the authorized activities. Interestingly, the cost of a liter of diesel is set as the unit of payment for fines, with one liter equaling a single "Fixed Unit" or UF (Unidades Fijas). Fines range from 100 to 300,000 UF. At the time of publication, information from Argentina suggests the UF is equivalent to just under 1.00 USD. Presumably, the legislators are trying to avoid a situation where a devaluation of the Argentine peso defangs the effectiveness of the penalty regime. Next up The approval of the new framework is only the beginning. ARICCAME now needs to be built up as an actual agency. It is possible that the new agency will prioritize the promulgation of application requirements, even as it is still figuring out where the light switches at its new digs are located. However, we are not counting on that, and would not expect any meaningful pronouncements until late this year, if that. Big picture, one thing to keep in mind is that Argentina will hold presidential elections in October 2023. This may not be much of a factor in how ARICCAME proceeds, but it could be important in terms of overall policy direction. Check Out Our Cannabis Law Services Share Twitter Facebook LinkedIn E-mail Comment Fred Rocafort Fred leads Harris Sliwoski’s intellectual property practice and is the coordinator of the firm’s international team. Much of Fred’s practice consists of helping cannabis businesses protect their brands. He also works with entrepreneurs and companies entering the Web3 space, a new frontier for IP law. Prior to joining Harris Sliwoski, Fred worked overseas for more than a decade, in both government and private sector roles. Fred is a regular contributor to the award-winning China Law Blog and Canna Law Blog. Fred began his career overseas as a U.S. consular officer in Guangzhou, China, where he advocated for fairer treatment of American companies and citizens in China and for stronger intellectual property rights enforcement. After entering the private sector, Fred worked at a Shanghai law firm as a foreign legal advisor and later joined one of the oldest American law firms in China, helping foreign companies navigate the Chinese legal environment. He also led the legal team at a Hong Kong-based brand protection consultancy, spending most of his time out in the field, protecting clients against counterfeiters and fraudsters in Greater China, Southeast Asia and Latin America. In addition to his IP work, as a native Spanish speaker, Fred works closely with different Harris Sliwoski teams on Latin America and Spain matters. Fred also provides advice to cannabis industry participants and other businesses on import and export transactions. Fred is an ardent supporter of FC Barcelona—and would be even in the absence of Catalan forebears who immigrated to Puerto Rico in the mid-1800s. Harris Sliwoski Attorney Read more posts [email protected] Read More Hemp/CBD, International Cannabis Law, Medical Marijuana Related Posts September 25, 2026 DEA Enforcement in a Changing Cannabis Landscape: Rescheduling, Hemp, and What Comes Next September 17, 2026 The Supreme Court May Decide if Cannabis-Related Residency Requirements are Unconstitutional September 16, 2026 A $31.8 Million Cannabis-Related Verdict That a Federal Court Wouldn’t Enforce September 15, 2026 Jason Adelstone Moderates Federal Cannabis Policy Discussion at IgniteIt Denver September 11, 2026 Medical Marijuana in Schedule III Survives Its First Major Challenge September 10, 2026 How to Acquire a Colorado Cannabis License September 4, 2026 The Intoxicating Hemp Products Ban Was Delayed a Month. Now What? August 31, 2026 Is the Global Shift to the Right Threatening International Cannabis Reforms? August 28, 2026 Oregon Cannabis Roundup: Fall 2026 August 26, 2026 Five Bills Every California Cannabis Operator Needs to Track in 2026 August 14, 2026 California Cannabis Contracts After Rescheduling: Why Your Contracts Need a Second Look August 4, 2026 DCC License Conversions After Rescheduling: How and When to Split A/M Licenses in California August 3, 2026 The Contradictions of Cannabis Law: From the United States to International Treaties July 28, 2026 What California Operators Must Do After Rescheduling: DEA Registration, License Restructuring, and 280E July 24, 2026 Medical Marijuana Schedule III Litigation: The D.C. Circuit's First Major Test Leave a comment Cancel reply